- Home
- BANX vs LFCR Comparison
BANX vs LFCR Comparison
Compare BANX & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BANX | LFCR |
|---|---|---|
| Founded | N/A | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.4M | 241.8M |
| IPO Year | 2013 | 1996 |
Fundamental Metrics
Financial Performance| Metric | BANX | LFCR |
|---|---|---|
| Price | $19.75 | $6.40 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.28 |
| AVG Volume (30 Days) | 33.9K | ★ 715.6K |
| Earning Date | 01-01-0001 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $18.45 | $3.63 |
| 52 Week High | $22.50 | $8.98 |
Technical Indicators
Market Signals| Indicator | BANX | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 42.12 | 71.55 |
| Support Level | $19.31 | $4.20 |
| Resistance Level | $19.78 | $6.48 |
| Average True Range (ATR) | 0.36 | 0.05 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 34.19 | 22.22 |
Price Performance
Historical ComparisonAbout BANX ArrowMark Financial Corp.
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. The Fund's objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.